{{Rsnum
|rsid=12409639
|Gene=SLC45A3
|Chromosome=1
|position=205669094
|Orientation=plus
|GMAF=0.107
|Gene_s=SLC45A3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 3.1 | 96.9
| HCB | 4.4 | 26.7 | 68.9
| JPT | 0.0 | 24.4 | 75.6
| YRI | 4.8 | 16.1 | 79.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 4.4 | 26.7 | 68.9
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23269536
  |Trait=Prostate-specific antigen levels
  |Title=Genome-wide association study identified novel genetic variant on SLC45A3 gene associated with serum levels prostate-specific antigen (PSA) in a Chinese population.
  |RiskAllele=A
  |Pval=2E-19
  |OR=.20
  |ORtxt=[NR] % higher levels
  }}

{{on chip | HumanOmni1Quad}}